Defunct Company
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
55
NCT02439398
Safety and Efficacy Evaluation of Intracoronary Infusion of Allogeneic Human Cardiac Stem Cells in Patients With AMI
Phase: Phase 1/2
Role: Lead Sponsor
Start: Jun 30, 2014
Completion: Nov 14, 2016